SCHEMBL2514960

SCHEMBL2514960

COC1CCN(CCOc2n[nH]c3cncc(Nc4ccc(OCc5ccccc5)c(C)c4)c23)CC1

nearest known ligand 0.52

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 16/20 0.52
EGFR P00533 15/20 0.51
LRRK2 Q5S007 2/20 0.37
CYP3A4 P08684 1/20 0.37
KCNH2 Q12809 1/20 0.37
SLCO1B1 Q9Y6L6 1/20 0.37
CSF1R P07333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2540445 0.93 ERBB2 (0.61) ERBB2EGFRLRRK2
SCHEMBL2518340 0.91 ERBB2 (0.49) ERBB2EGFR
SCHEMBL1406486 0.84 ERBB2 (0.72) ERBB2EGFR
SCHEMBL2538192 0.83 ERBB2 (0.42) ERBB2EGFRLRRK2
SCHEMBL2539476 0.83 ERBB2 (0.60) ERBB2EGFRCSF1R
SCHEMBL2519145 0.80 EGFR (0.59) ERBB2EGFR
SCHEMBL2542809 0.79 CTSV (0.39) ERBB2EGFRLRRK2CSF1R
SCHEMBL2522164 0.79 ERBB2 (0.69) ERBB2EGFR
SCHEMBL2537030 0.78 ERBB2 (0.73) ERBB2EGFR
SCHEMBL1406327 0.77 ERBB2 (0.85) ERBB2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838712-B8 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2011-10-12 EP claimed
EP-1838712-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2007-10-03 EP claimed
WO-2006064196-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2006-06-22 WO claimed